Lake Macquarie Private Hospital joins breast cancer clinical trial
The Phase III open-label study plans to enlist approximately 5,500 patients across 700 sites in 40 countries.
The Phase III open-label study plans to enlist approximately 5,500 patients across 700 sites in 40 countries.
A new initiative will guide regional governments and stakeholders in financing NCD treatment in low- and middle-income countries.
The healthcare industry continues to be a hotbed of patent innovation. Activity is driven by telemedicine, real-time diagnostics, smart hospitals...
Huawei’s top 10 construction principles for intelligent computing centre facilities
Konica Minolta introduces cloud-based image management solution for hospitals
Trump 2.0 spells uncertainty for US healthcare, says analyst
GPs call for assurances about NI hike